{
    "Trade/Device Name(s)": [
        "VIDAS Troponin I Ultra (TNIU) Assay"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K063243",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "December 14, 2007",
    "Summary Letter Received Date": "September 17, 2007",
    "Submission Date": "September 14, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine Phosphokinase/Creatine Kinase or Isoenzymes Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac troponin I"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (lithium heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VIDAS instruments"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-Linked Fluorescent Assay (ELFA)",
        "Enzyme immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Fluorescent detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VIDAS Troponin I Ultra (TNIU) automated immunoassay for cardiac troponin I detection on VIDAS instruments",
    "Indications for Use Summary": "Automated quantitative assay for cardiac troponin I in serum or plasma (lithium heparin) using ELFA technology, intended as an aid in the diagnosis of myocardial infarction",
    "fda_folder": "Clinical Chemistry"
}